The neurochemistry of epilepsy, inhibitory neurotransmission and experimental models: New perspectives;Neuroquímica de la epilepsia, neurotransmisión inhibitoria y modelos experimentales: Nuevas perspectivas

Revista de Neurologia

Volumn 42, Issue 3, 2006, Pages 159-168

  De Cabo de La Vega, C ^a,b   Villanueva Hernandez P ^a   Prieto Martin A ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

Animal models; Channelopathies; Epilepsy; GABA; KCC2; Loop diuretics; Neurogenetics; Receptors

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; AMILORIDE; ANTICONVULSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; ION CHANNEL; LOOP DIURETIC AGENT; POTASSIUM CHLORIDE; PROTEIN SUBUNIT; TOPIRAMATE; 4 AMINOBUTYRIC ACID; COTRANSPORTER; POTASSIUM CHLORIDE SYMPORTERS; POTASSIUM-CHLORIDE SYMPORTERS;

BRAIN DEPTH STIMULATION; BRAIN DEVELOPMENT; CELL MATURATION; EPILEPSY; EXPERIMENTAL STUDY; GABAERGIC SYSTEM; GENE MUTATION; GENETIC CODE; HEREDITY; HUMAN; HYPERPOLARIZATION; MOLECULAR DYNAMICS; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PHYLOGENY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; ANIMAL; BRAIN LEVEL; CHEMISTRY; DISEASE MODEL; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; ION CHANNELS; RECEPTORS, GABA; SYMPORTERS; SYNAPTIC TRANSMISSION;

EID: 33749186820     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4203.2005674     Document Type: Review

References (137)

1. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-9.
2. Sayin U, Osting S, Hagen J, Rutecki P, Sutula T. Spontaneous seizures and loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled rats. J Neurosci 2003; 23: 2759-68.
3. Ross KC, Coleman JR. Developmental and genetic audiogenic seizure models: behavior and biological substrates. Neurosci Biobehav Rev 2000; 24: 639-53.
4. García-Cairasco N. A critical review on the participation of inferior colliculus in acoustic-motor and acoustic-limbic networks involved in the expression of acute and kindled audiogenic seizures. Hear Res 2002; 168: 208-22.
5. Romcy-Pereira RN, García-Cairasco N. Hippocampal cell proliferation and epileptogenesis after audiogenic kindling are not accompanied by mossy fiber sprouting or fluoro-jade staining. Neuroscience 2003; 119: 533-46.
6. Galvis-Alonso OY, Cortes De Oliveira JA, García-Cairasco N. Limbic epileptogenicity, cell loss and axonal reorganization induced by audiogenic and amygdala kindling in wistar audiogenic rats (WAR strain). Neuroscience 2004; 125: 787-802.
7. DeFelipe J. Types of neurons, synaptic connections and chemical characteristics of cells immunoreactive for calbindin-D28K, parvalbumin and calretinin in the neocortex. J Chem Neuroanat 1997; 14: 1-19.
8. McBain CJ, Fisahn A. Interneurons unbound. Nat Rev Neurosci 2001; 2: 11-23.
9. Cossart R, Bernard C, Ben-Ari Y. Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci 2005; 28: 108-15.
10. Hestrin S, Galarreta M. Synchronous versus asynchronous transmitter release: a tale of two types of inhibitory neurons. Nat Neurosci 2005; 8: 1283-4.
11. Hefft S, Jonas P. Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 2005; 8: 1319-28.
12. Xu Q, Cobos I, De la Cruz E, Rubenstein JL, Anderson SA. Origins of cortical interneuron subtypes. J Neurosci 2004; 24: 2612-22.
13. Marco P, Sola RG, Pulido P, Alijarde MT, Sánchez A, Ramón y Cajal S, DeFelipe J. Inhibitory neurons in the human epileptogenic temporal neocortex. An immunocytochemical study. Brain 1996; 119: 1327-47.
14. Buzsaki G. Theta oscillations in the hippocampus. Neuron 2002; 33: 325-40.
15. Cossart R, Dinocourt C, Hirsch JC, Merchan-Pérez A, De Felipe J, Ben-Ari Y, et al. Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy. Nat Neurosci 2001; 4: 52-62.
16. Meguro R, Lu J, Gavrilovici C, Poulter MO. Static, transient and permanent organization of GABA receptor expression in calbindin-positive interneurons in response to amygdala kindled seizures. J Neurochem 2004; 91: 144-54.
17. Sanon N, Carmant L, Emond M, Congar P, Lacaille JC. Short-term effects of kainic acid on CA1 hippocampal interneurons differentially vulnerable to excitotoxicity. Epilepsia 2005; 46: 837-48.
18. Maccaferri G, Lacaille JC. Interneuron diversity series: hippocampal interneuron classifications-making things as simple as possible, not simpler. Trends Neurosci 2003; 26: 564-71.
19. Monyer H, Markram H. Interneuron diversity series: molecular and genetic tools to study GABAergic interneuron diversity and function. Trends Neurosci 2004; 27: 90-7.
20. Markram H, Toledo-Rodríguez M, Wang Y, Gupta A, Silberberg G, Wu C. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 2004; 5: 793-807.
21. Pouille F, Scanziani M. Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition. Science 2001; 293: 1159-63.
22. Jonas P, Bischofberger J, Fricker D, Miles R. Interneuron diversity series: fast in, fast out, temporal and spatial signal processing in hippocampal interneurons. Trends Neurosci 2004; 27: 30-40.
23. Cohen I, Miles R. Contributions of intrinsic and synaptic activities to the generation of neuronal discharges in vitro hippocampus. J Physiol 2000; 524, 485-502.
24. Freund TF, Buzsáki G. Interneurons of the hippocampus. Hippocampus 1996; 6: 347-470.
25. + channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Nature 1997; 387: 869-75.
26. Miles R, Toth K, Gulyas AI, Hajos N, Freund TF. Differences between somatic and dendritic inhibition in the hippocampus. Neuron 1996; 16: 815-23.
27. Cobb SR, Buhl EH, Halasy K, Paulsen O, Somogyi P. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 1995; 378: 75-8.
28. Klausberger T, Magill PJ, Marton LF, Roberts JD, Cobden PM, Buzsaki G, et al. Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. Nature 2003; 421: 844-8.
29. Whittington MA, Stanford IM, Colling SB, Jefferys JG, Traub RD. Spatiotemporal patterns of gamma frequency oscillations tetanically induced in the rat hippocampal slice. J Physiol 1997; 502: 591-607.
30. Mischel PS, Nguyen LP, Vinters HV. Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 1995; 54: 137-53.
31. Sprefacio R, Pasquier S, Minotti L, Garbelli R, Kahane P, Grand S, et al. Inmunocytochemical investigation on dysplastic human tissue from epileptic patients. Epilepsy Res 1998; 32: 34-48.
32. Spreafico R, Tassi L, Colombo N, Bramerio M, Galli C, Garbelli R, et al. Inhibitory circuits in human dysplastic tissue. Epilepsia 2000; 41 (Suppl 6): S168-73.
33. Arnold S, Berthele A, Drzezga A, Töller TR, Weis S, Werhahn KJ, et al. Reduction of benzodiazepine receptor binding is related to the seizure onset zone in extratemporal focal cortical dysplasia. Epilepsia 2000; 41: 818-24.
34. Benardete EA, Kriegstein AR. Increased excitability and decreased sensitivity to GABA in an animal model of dysplastic cortex. Epilepsia. 2002; 43: 970-82.
35. Sata Y, Matsuda K, Mihara T, Aihara M, Yagi K, Yonekura Y. Quantitative analysis of benzodiazepine receptor in temporal lobe epilepsy: [125I]iomazenil autoradiographic study of surgically resected specimens. Epilepsia 2002; 43: 1039-48.
36. Roper SN, Yachnis AT. Cortical dysgenesis and epilepsy. Neuroscientist 2002; 8: 356-71.
37. A receptor-dependent synchronization leads to ictogenesis in the human dysplastic cortex. Brain 2004; 127: 1626-40.
38. Calcagnotto ME, Paredes MF, Tihan T, Barbaro NM, Baraban SC. Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J Neurosci 2005; 25: 9649-57.
39. Calcagnotto ME, Paredes MF, Baraban SC. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation-associated epilepsy. J Neurosci 2002; 22: 7596-605.
40. Najm I, Ying Z, Babb T, Crino PB, Macdonald R, Mathern GW, et al. Mechanisms of epileptogenicity in cortical dysplasias. Neurology 2004; 62 (Suppl 3): S9-13.
41. Schwartzkroin PA, Roper SN, Wenzel HJ. Cortical dysplasia and epilepsy: animal models. Adv Exp Med Biol 2004; 548: 145-74.
42. Arabadzisz D, Antal K, Parpan F, Emri Z, Fritschy JM. Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus. Exp Neurol 2005; 194: 76-90.
43. Tschuluun N, Wenzel JH, Katleba K, Schwartzkroin PA. Initiation and spread of epileptiform discharges in the methylazoxymethanol acetate rat model of cortical dysplasia: functional and structural connectivity between CA1 heterotopia and hippocampus/neocortex. Neuroscience 2005; 133: 327-42.
44. Crespel A, Rigau V, Coubes P, Rousset MC, de Bock F, Okano H, et al. Increased number of neural progenitors in human temporal lobe epilepsy. Neurobiol Dis 2005; 19: 436-50.
45. Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 2004; 73:1-60.
46. Arellano JI, Muñoz A, Ballesteros-Yánez I, Sola RG, DeFelipe J. Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain 2004; 127: 45-64.
47. Cobos I, Calcagnotto ME, Vilaythong AJ, Thwin MT, Noebels JL, Baraban SC, et al. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci 2005; 8: 1059-68.
48. Gorter JA, Van Vliet EA, Aronica E, Lopes da Silva FH. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur J Neurosci 2001; 13: 657-69.
49. DeFelipe J. Chandelier cells and epilepsy. Brain 1999; 122: 1807-22.
50. DeFelipe J, Arellano JI, Alonso L, Muñoz A. Neuropatología de la epilepsia del lóbulo temporal. Alteraciones primarias y secundarias de los circuitos corticales y epileptogenicidad. Rev Neurol 2002; 34: 401-8.
51. Golarai G, Greenwood AC, Feeney DM, Connor JA. Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury. J Neurosci 2001; 21: 8523-37.
52. A receptor function in dentate granule and CA1 neurons. J Neurophysiol 1997; 77: 1924-38.
53. A receptors underlies potentiation at hippocampal inhibitory synapses. Nature 1998; 395: 172-7.
54. Otis TS, De Koninck Y, Mody I. Lasting potentiation of inhibition is associated with an increased number of gamma-aminobutyric acid type A receptors activated during miniature inhibitory postsynaptic currents. Proc Natl Acad Sci U S A 1994; 91: 7698-702.
55. Bausch SB. Axonal sprouting of GABAergic interneurons in temporal lobe epilepsy. Epilepsy Behav 2005; 7: 390-400.
56. Fuentes-Santamaría V, Cantos R, Alvarado JC, García-Atares N, López DE. Morphologic and neurochemical abnormalities in the auditory brainstem of the genetically epilepsy-prone hamster (GPG/Vall). Epilepsia 2005; 46: 1027-45.
57. Khalilov I, Holmes GL, Ben-Ari Y. In vitro formation of a secondary epileptogenic mirror focus by interhippocampal propagation of seizures. Nat Neurosci 2003; 6: 1079-85.
58. A receptor subunit expression and function in temporal lobe epilepsy. Nat Med 1998; 4: 1166-72.
59. Sperk G, Furtinger S, Schwarzer C, Pirker S. GABA and its receptors in epilepsy. Adv Exp Med Biol 2004; 548: 92-103.
60. B receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience 2005; 134: 691-704.
61. Bernard C, Anderson A, Becker A, Poolos NP, Beck H, Johnston D. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 2004; 305: 532-5.
62. A receptor channel function in the nervous system. Prog Neurobiol 1994; 42: 489-537.
63. Chavas J, Marty A. Coexistence of excitatory and inhibitory GABA synapses in the cerebellar interneuron network. J Neurosci 2003; 23: 2019-31.
64. Gulledge AT, Stuart GJ. Excitatory actions of GABA in the cortex. Neuron 2003; 37: 299-309.
65. Chen K, Aradi I, Thon N, Eghbal-Ahmadi M, Baram TZ, Soltesz I. Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med 2001; 7: 331-7.
66. Poolos NP. The h-channel: a potential channelopathy in epilepsy? Epilepsy Behav 2005; 7: 51-6.
67. Pare D, Lang EJ, Destexhe A. Inhibitory control of somatodendritic interactions underlying action potentials in neocortical pyramidal neurons in vivo: an intracellular and computational study. Neuroscience 1998; 84: 377-402.
68. Liu G. Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites. Nat Neurosci 2004; 7: 373-9.
69. Lerma J, Mora F, Sánchez Prieto J. Sinapsis aminoacidé rgicas y peptidérgicas. En Delgado JM, Ferrús A, Mora F, Rubia FJ, eds. Manual de neurociencia. Madrid: Síntesis; 1998. p. 231-48.
70. A receptors. Brain Res Brain Res Rev 1999; 29: 196-217.
71. A receptor subtypes really occur in the brain? Trends Neurosci 1996; 19: 139-43.
72. A receptor in a mouse model of temporal lobe epilepsy. J Neurosci 2004; 24: 8629-39.
73. Conley EC, William BW. The ion channel 'facts book' I. Extracellular ligand-gated channels. San Diego: Academic Press; 1996.
74. Wang XJ, Buzsaki G. Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model. J Neurosci 1996; 16: 6402-13.
75. Traub RD, Whittington MA, Colling SB, Buzsaki G, Jefferys JG. Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo. J Physiol 1996; 493: 471-84.
76. A receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci 1992; 12: 1063-76.
77. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 1992; 12: 1040-62.
78. A receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 1992; 12: 4151-72.
79. A receptor subunits in rat brainstem auditory pathways: cochlear nuclei, superior olivary complex and nucleus of the lateral lemniscus. Neuroscience 2001; 102: 625-38.
80. A en dos núcleos de la vía auditiva de la vía. Rev Neurol 1999; 30 (Separata): 247.
81. A receptor subunits in the medial geniculate body of the rat. Abstr Soc Neurosci 1999; 22: 1790.
82. A receptor subunits in the superior olivary complex of the rat. Eur J Neurosci 2000; 12 (Suppl 11): 44.
83. A receptor-mediated inhibitory post synaptic currents in dentate granule cells in epileptic hippocampus. J Neurophysiol 1996; 75: 1901-8.
84. A receptor function in epileptic human dentate granule cells: comparison to epileptic and control rat. Epilepsy Res 1998; 32: 114-28.
85. A receptors in temporal lobe epilepsy. Neurochem Int 1999; 34: 435-45.
86. Loup F, Wieser HG, Yonekawa Y, Aguzzi A, Fritschy JM. Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy. J Neurosci 2000; 20: 5401-19.
87. A receptor beta-subunits in the hippocampus of patients with temporal lobe epilepsy. J Neuropathol Exp Neurol 2003; 62: 820-34.
88. Coulter DA. Chronic epileptogenic cellular alterations in the limbic system after status epilepticus. Epilepsia 1999; 40 (Suppl 1): S23-S33.
89. Koepp MJ, Richardson MP, Brooks DJ, Poline JB, Van Paesschen W, Friston KJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis. An objective in vivo analysis. Brain 1996; 119: 1677-87.
90. A receptor expression in a mouse model of mesial temporal lobe epilepsy. Hippocampus 2000; 10: 305-24.
91. Buhl EH, Otis TS, Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 1996; 271: 369-73.
92. A receptor-mediated synaptic transmission in genetically seizure-prone and seizure-resistant rats. J Neurosci 2002; 22: 9922-31.
93. A receptors: modulating gain and maintaining the tone. Trends Neurosci 2004; 27: 262-9.
94. A receptors. Science 1995; 269: 977-81.
95. Hammond C. Cellular and molecular neurobiology. San Diego: Academic Press; 2001.
96. Ben Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 2002; 3: 728-39.
97. B receptor pharmacology. Annu Rev Pharmacol Toxicol 1993; 33: 109-47.
98. Furtinger S, Pirker S, Czech T, Baumgartner C. Increased expression of gamma-aminobutyric acid type B receptors in the hippocampus of patients with temporal lobe epilepsy. Neurosci Lett 2003; 352: 141-5.
99. B receptors in the hippocampus after kainic-acid-induced seizures in rats. Brain Res Mol Brain Res 2003; 113: 107-15.
100. B1 deficient mice. Mol Cell Neurosci 2001; 17: 1059-70.
101. B2-deficient mice. J Neurosci 2004; 24: 6086-97.
102. A2 receptor subunit. Epilepsy Res 2005; 65: 41-51.
103. Swann JW, Smith KL, Brady RJ. Localized excitatory synaptic interactions mediate the sustained depolarization of electrographic seizures in developing hippocampus. J Neurosci 1993; 13: 4680-9.
104. Holmes GL, Khazipov R, Ben-Ari Y. New concepts in neonatal seizures. Neuroreport 2002; 13: A3-8.
105. Lerche H, Weber YG, Jurkat-Rott K, Lehmann-Horn F. Ion channel defects in idiopathic epilepsies. Curr Pharm Des 2005; 11: 2737-52.
106. Behar TN, Schaffner AE, Scott CA, O'Connell C, Barker JL. Differential response of cortical plate and ventricular zone cells to GABA as a migration stimulus. J Neurosci 1998; 18: 6378-87.
107. Kandler K. Activity-dependent organization of inhibitory circuits: lessons from the auditory system. Curr Opin Neurobiol 2004; 14: 96-104.
108. A receptor stimulation. J Neurochem 1997; 68: 631-9.
109. De Cabo C, Campos ML, Juiz JM. Desarrollo posnatal de las subunidades del receptor de glicina: diferencias entre dos núcleos de la misma modalidad sensorial. Rev Neurol 2001; 33: 876.
110. B mediated inhibition and induction of epileptiform discharges in the neonatal rat hippocampus. Eur J Neurosci 2004; 19: 3227-34.
111. Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 2002; 298: 1418-21.
112. Hablitz JJ, DeFazio RA. Altered receptor subunit expression in rat neocortical malformations. Epilepsia 2000; 41 (Suppl 6): S82-5.
113. A receptor subunits in seizure-prone and seizure-resistant rat models of temporal lobe epilepsy. J Neurosci 1999; 19: 4654-61.
114. Williams JR, Sharp JW, Kumari VG, Wilson M, Payne JA. The neuron-specific K-Cl cotransporter, KCC2. Antibody development and initial characterization of the protein. J Biol Chem 1999; 274: 12656-64.
115. Stein V, Hermans-Borgmeyer I, Jentsch TJ, Hubner CA. Expression of the KCl cotransporter KCC2 parallels neuronal maturation and the emergence of low intracellular chloride. J Comp Neurol 2004; 468: 57-64.
116. Woo NS, Lu J, England R, McClellan R, Dufour S, Mouny DB, et al. Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene. Hippocampus 2002; 12: 258-68.
117. Tornberg J, Voikar V, Savilahti H, Rauvala H, Airaksinen MS. Behavioural phenotypes of hypomorphic KCC2-deficient mice. Eur J Neurosci 2005; 21: 1327-37.
118. Boettger T, Rust MB, Maier H, Seidenbecher T, Schweizer M, Keating DJ, et al. Loss of K-Cl co-transporter KCC3 causes deafness, neurodegeneration and reduced seizure threshold. EMBO J 2003; 22: 5422-34.
119. De Cabo C, Prieto-Martín AI, Vale C, Juiz JM, Viñuela A, Muñoz L, et al. Downregulated expression of the potassium-chloride cotransporter KCC2 in a novel animal model of genetic epilepsy. Abstr Soc Neurosci; 2004.
120. Rivera C, Voipio J, Thomas-Crusells J, Li H, Emri Z, Sipila S, et al. Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2. J Neurosci 2004; 24: 4683-91.
121. - extrusion. J Cell Biol 2002; 159: 747-52.
122. Reid KH, Li GY, Payne RS, Schurr A, Cooper NG. The mRNA level of the potassium-chloride cotransporter KCC2 covaries with seizure susceptibility in inferior colliculus of the post-ischemic audiogenic seizure-prone rat. Neurosci Lett 2001; 308: 29-32.
123. Reid KH, Guo SZ, Iyer VG. Agents which block potassium-chloride cotransport prevent sound-triggered seizures in post-ischemic audiogenic seizure-prone rats. Brain Res 2000; 864: 134-7.
124. Hesdorffer DC, Stables JP, Hauser WA, Annegers JF, Cascino G. Are certain diuretics also anticonvulsants? Ann Neurol 2001; 50: 458-62.
125. Kanner AM. Diuretics as antiepileptic drugs. Epilepsy Curr 2002; 2: 39-40.
126. Haglund MM, Hochman DW. Furosemide and mannitol suppression of epileptic activity in the human brain. J Neurophysiol 2005; 94: 907-18.
127. Resor SR, Resor LD, Woodbury DM, Kemp JW. Acetazolamide. In Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4 ed. New York: Raven Press; 2002. p. 969-85.
128. Katayama F, Miura H, Takanashi S. Long-term effectiveness and side effects of acetazolamide as an adjunct to other anticonvulsants in the treatment of refractory epilepsies. Brain Dev 2002; 24: 150-4.
129. Varadkar S, Duncan JS, Cross JH. Acetazolamide and autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2003; 44: 986-7.
130. Boettger T, Hubner CA, Maier H, Rust MB, Beck FX, Jentsch TJ. Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4. Nature 2002; 416: 874-8.
131. Leniger T, Wiemann M, Bingmann D, Widman G, Hufnagel A, Bonnet U. Carbonic anhydrase inhibitor sulthiame reduces intracellular pH and epileptiform activity of hippocampal CA3 neurons. Epilepsia 2002; 43: 469-74.
132. Pérez-Velázquez JL. Bicarbonate-dependent depolarizing potentials in pyramidal cells and interneurons during epileptiform activity. Eur J Neurosci 2003; 18: 1337-42.
133. Ali A, Ahmad FJ, Pillai KK, Vohora D. Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav 2004; 5: 322-8.
134. Armijo JA, Valdizan EM, De Las Cuevas I, Cuadrado A. Avances en la fisiopatología de la epileptogénesis: aspectos moleculares. Rev Neurol 2002; 34: 409-29.
135. Gutiérrez-Delicado E, Serratosa JM. Genetics of the epilepsies. Curr Opin Neurol 2004; 17: 147-53.
136. Blandfort M, Tsuboi T, Vogel F. Genetic counseling in the epilepsies. I. Genetic risks. Hum Genet 1987; 76: 303-31.
137. Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998; 43: 435-45.